Studies on the antiviral effect of rifampicin in volunteers.
D000906:Antibodies / Q000032:analysis*; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D011213:Poxviridae Infections / Q000276:immunology*; D012293:Rifampin / Q000008:administration & dosage*; D014611:Vaccination; D014616:Vaccinia virus; D014765:Viral Vaccines / Q000627:therapeutic use*
D000906:Antibodies; D014765:Viral Vaccines; D012293:Rifampin